Delivery Order SPE2DB20D2001-SPE2DB25FPNQU
Award Date 9/3/25
Potential Completion Date 9/4/25
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $21,523.36 to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 12.5 mg/0.5 mL pen injections. The contract, awarded on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will be executed from AmerisourceBergen's Conshohocken, Pennsylvania facility, which serves as the company's corporate headquarters. This...
- The Defense Logistics Agency (DLA) awarded a $1,525.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pen injectors. The award was completed competitively with no set-aside designation and carries an ultimate completion date of September 17, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a $5,834.04 delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Zepbound (tirzepatide) 15 mg/0.5 ml pen injectors. This non-competitive, firm fixed-price delivery order is set to be completed by September 5, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Zepbound (tirzepatide) 2.5 mg/0.5 ml pen injectors in 0.5 ml quantities. This firm fixed-price delivery order, valued at $9,394.59, represents a competitive award with no set-aside designation and is set for completion by August 1, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, serving the federal medical...
- The Defense Logistics Agency awarded a $7,993.05 firm fixed price delivery order to AmerisourceBergen Drug Corp for ZEPBOUND (tirzepatide) 5 mg/0.5 ml pen injections on August 18, 2025, with an ultimate completion date of August 19, 2025. This non-competitive delivery order represents a single-use purchase of the FDA-approved diabetes and weight management medication under the company's existing contract vehicle. The performance location is AmerisourceBergen's corporate office in Conshohocken,...
- The Defense Logistics Agency awarded a $13,027.34 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Zepbound (tirzepatide) 15 mg/0.5 ml pens, with an ultimate completion date of September 4, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pen injectors valued at $7,436.99. This competitively awarded, firm fixed-price contract is classified as a delivery order with an ultimate completion date of August 18, 2025, and involves performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Zepbound (tirzepatide) 10 mg/0.5 mL pen injections with a ceiling value of $1,525.20. This competitive award, issued on September 3, 2025, with an ultimate completion date of September 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contractor will perform at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at approximately $43.3K to AmerisourceBergen Drug Corp for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL pens on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $1,143.89 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Zepbound (tirzepatide) 5 mg/0.5 mL injectable pens. This competitively awarded, firm fixed-price delivery order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. No set-aside designation was applied to this award. This delivery order represents a child contract under...